Perrigo requests 18-month extension of PPA warning label effective date.
This article was originally published in The Tan Sheet
Executive Summary
PERRIGO REQUESTS PPA LABEL-WARNING EXTENSION from the six-month period proposed by FDA to an 18-month period in May 13 comments to the agency. FDA, in a Feb. 14 Federal Register notice, proposed new warning labeling requirements for all OTC drugs containing phenylpropanolamine (PPA) ("The Tan Sheet" Feb. 19, p. 9).
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning